- $231.00m
- $1.27bn
- $0.08m
Annual balance sheet for Prokidney, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4.58 | 20.6 | 490 | 363 | 358 |
| Net Total Receivables | — | — | — | 1.38 | 2.45 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5.58 | 27.3 | 505 | 374 | 396 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 10.5 | 12.6 | 13.1 | 46.4 | 45.2 |
| Net Intangible Assets | |||||
| Total Assets | 16.7 | 40.3 | 518 | 421 | 441 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.5 | 12.3 | 10.9 | 25 | 36.2 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.84 | 13.4 | 1,615 | 1,524 | 1,436 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 9.86 | 26.9 | -1,097 | -1,103 | -995 |
| Total Liabilities & Shareholders' Equity | 16.7 | 40.3 | 518 | 421 | 441 |
| Total Common Shares Outstanding |